Floatz logo

Nandrolone Decanoate

Bone Marrow Failure Syndrome

University of Sao PauloSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Bone Marrow Failure Syndrome cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2/3BBB
Cyclophosphamide
Memorial Sloan Kettering Cancer Center
Phase 2/3BBB
Thiotepa
Fred Hutchinson Cancer Center
Phase 2BB
Alemtuzumab
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2/3BB
Busulfanum
Memorial Sloan Kettering Cancer Center
Phase 2/3BB

View all 30 →

Same molecule, other indications

Nandrolone Decanoate is also rated in:

telomere syndromeDormant
CCC
Indicative · Phase 1/2
52 / 100
View asset →
HIV wasting syndromeDormant
CC
Indicative · Phase 1
47 / 100
View asset →
idiopathic pulmonary fibrosisDormant
CC
Indicative · Phase 1/2
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →